What is the step‑by‑step protocol to wean a hemodynamically stable adult intubated patient (blood pressure ≥90 mmHg without vasopressors, PaO₂/FiO₂ ratio ≥200 mmHg, respiratory rate ≤30 breaths/min, tidal volume ≥5 mL/kg predicted body weight, adequate cough, and Richmond Agitation‑Sedation Scale –1 to 0) for extubation using continuous positive airway pressure (CPAP) mode?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

CPAP-Based Weaning Protocol for Extubation

For hemodynamically stable intubated adults meeting readiness criteria, conduct the spontaneous breathing trial (SBT) using CPAP with modest inspiratory pressure augmentation (5-8 cm H₂O) rather than CPAP alone or T-piece, as this approach increases both SBT success rates and extubation success rates. 1

Step-by-Step Protocol

Phase 1: Confirm Readiness Criteria (Screening)

Before initiating any SBT, verify ALL of the following:

  • Hemodynamic stability: BP ≥90 mmHg without vasopressors
  • Oxygenation: PaO₂/FiO₂ ratio ≥200 mmHg
  • Respiratory mechanics:
    • Respiratory rate ≤30 breaths/min
    • Tidal volume ≥5 mL/kg predicted body weight
  • Airway protection: Adequate cough strength
  • Mental status: Richmond Agitation-Sedation Scale –1 to 0
  • Sedation minimized: Use protocols to reduce sedation before weaning 1

Phase 2: Conduct the SBT with Pressure-Augmented CPAP

Initial Settings:

  • Set pressure support at 5-8 cm H₂O (most commonly 7 cm H₂O) 1, 2
  • Maintain PEEP at 5 cm H₂O or current level
  • FiO₂ ≤50%
  • Duration: 30 minutes to 2 hours 1

Monitor continuously for signs of failure:

  • Respiratory rate ≥25/min or increase ≥50% from baseline
  • Heart rate ≥140/min or increase ≥20% from baseline
  • SpO₂ ≤90% despite FiO₂ ≥50%
  • Systolic BP >180 mmHg or <90 mmHg
  • Signs of respiratory distress (accessory muscle use, paradoxical breathing, diaphoresis, agitation)

Key measurement parameters (assess after >15 minutes): 2

  • Tidal volume (from ventilator display)
  • Respiratory rate
  • Rapid shallow breathing index (RR/TV) - keep <80 breaths/min/L
  • Oxygen saturation

Phase 3: Decision Point After SBT

If SBT is successful (no failure signs for 30 min-2 hours):

  • Proceed to extubation
  • For high-risk patients (hypercapnia, COPD, CHF, serious comorbidities), apply preventive NIV immediately after extubation 1, 3
  • Provide supplemental oxygen as needed

If SBT fails:

  • Resume full ventilatory support
  • Address reversible causes (secretions, bronchospasm, fluid overload, inadequate sedation management)
  • Retry SBT daily once readiness criteria are re-met 4

Critical Implementation Points

Why pressure augmentation matters: Meta-analysis shows pressure-augmented SBTs (5-8 cm H₂O) produce higher SBT success rates (84.6% vs 76.7%) and extubation success rates (75.4% vs 68.9%) compared to CPAP alone or T-piece 1. The modest pressure support overcomes work of breathing imposed by the endotracheal tube while still testing weaning readiness.

Common pitfall to avoid: Do NOT use gradual pressure support reduction between SBTs as a weaning strategy. Evidence shows daily SBT protocols are superior to gradual weaning approaches 4. The pressure support is for the SBT itself, not for inter-trial ventilation.

Protocol-driven approach: Use ventilator liberation protocols implemented by respiratory therapists/nurses rather than physician judgment alone, as this reduces mechanical ventilation duration by approximately 25 hours and ICU stay by 1 day 4.

Post-extubation management: High-risk patients benefit from immediate preventive NIV (strong recommendation), which significantly improves outcomes when applied right after extubation rather than waiting for respiratory failure to develop 1, 3.

Related Questions

How should I proceed to wean and extubate a patient who is on volume-controlled continuous mandatory ventilation (CMV‑VC) mode?
What is the recommended approach to wean a patient off inotropic support when they cannot be weaned?
What is the stepwise sprint weaning protocol for clinically stable intubated infants, including criteria for spontaneous breathing trials and extubation?
What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
What are the appropriate admission orders for a patient experiencing an acute exacerbation of chronic congestive heart failure?
Based on my lipid panel (total cholesterol 143 mg/dL, triglycerides 63 mg/dL, HDL 45 mg/dL, LDL 86 mg/dL, VLDL 13 mg/dL, cholesterol/HDL ratio 3.2) and the fact that I am not taking a statin, what treatment or lifestyle recommendations are indicated?
Can a patient who takes quetiapine 50–100 mg on 2–3 nights per week taper the quetiapine while increasing trazodone or gabapentin to avoid rapid discontinuation and mood destabilization?
When is it appropriate to transition a patient from intravenous to oral loop diuretics?
What is the appropriate treatment for a patient with Elizabethkingia meningoseptica isolated from blood cultures?
What are the lowest safe parameters for synchronized intermittent mandatory ventilation (SIMV) on a mechanical ventilator?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.